Soluble to 100 mM in DMSO and to 100 mM in ethanol
Usage And Synthesis
Uses
VU0134992 is the first subtype-preferring, orally active and selective Kir4.1 potassium channel pore blocker, with an IC50 of 0.97 μM. VU0134992 is 9-fold selective for homomeric Kir4.1 over Kir4.1/5.1 concatemeric channels (IC50=9 μM) at -120 mV[1].
in vivo
VU0134992 (50-100 mg/kg; oral gavage) statistically significantly increased urinary Na+ as well as K+ excretion[1].
Animal Model:
Male Sprague-Dawley rats (250-300 g)[1]
Dosage:
50 and 100 mg/kg
Administration:
Oral gavage
Result:
Statistically significantly increased urinary Na+ as well as K+ excretion
storage
Store at -20°C
References
[1] Kharade SV, et al. Discovery, Characterization, and Effects on Renal Fluid and Electrolyte Excretion of the Kir4.1 Potassium Channel Pore Blocker, VU0134992. Mol Pharmacol. 2018 Aug;94(2):926-937. DOI:10.1124/mol.118.112359